SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters. (Q45878407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Jayan GC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Patel C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

BouHamdan M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Johnson RP

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Lisziewicz J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pomerantz RJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Strayer DS

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1033-1042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301481

9 November 2019

exact match

0 references

cites work

Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

The transcriptional start site for a human U6 small nuclear RNA gene is dictated by a compound promoter element consisting of the PSE and the TATA box

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Expression of small, therapeutic RNAs in human cell nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Extensive variation of human immunodeficiency virus type-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Gene therapy using SV40-derived vectors: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Prospects for adoptive T cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Deficient cellular immunity--finding and fixing the defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Gene delivery to the liver using simian virus 40-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

Growth and purification of SV40 virus for biochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

inferred from DOI database lookup

7 January 2021

based on heuristic

Effective gene transfer using viral vectors based on SV40

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

inferred from DOI database lookup

7 January 2021

based on heuristic

Titering replication-defective virus for use in gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301481

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438838%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 November 2019

0 references

1 reference